- Home
- HOFT vs WHWK Comparison
HOFT vs WHWK Comparison
Compare HOFT & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOFT | WHWK |
|---|---|---|
| Founded | 1924 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.9M | 95.2M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | HOFT | WHWK |
|---|---|---|
| Price | $10.42 | $2.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 29.2K | ★ 185.6K |
| Earning Date | 12-11-2025 | 11-06-2025 |
| Dividend Yield | ★ 8.73% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $375,494,000.00 | $14,384,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.29 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.34 | $1.39 |
| 52 Week High | $18.51 | $3.81 |
Technical Indicators
Market Signals| Indicator | HOFT | WHWK |
|---|---|---|
| Relative Strength Index (RSI) | 58.36 | 58.02 |
| Support Level | $8.88 | $2.10 |
| Resistance Level | $11.74 | $2.63 |
| Average True Range (ATR) | 0.83 | 0.15 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 77.33 | 79.25 |
Price Performance
Historical ComparisonAbout HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.